8-K - Cronos Group Inc. (0001656472) (Filer)
Published . Updated .
Key takeaways
- 8-K - Cronos Group filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
- Exposed: CRON
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Cronos Group filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
Directly affected
- CRON Cronos Group+0.6% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Cronos Group belongs to, so it often moves with news about it.
- RGC Regencell Bioscience Holdings+17.2% 6d
Regencell Bioscience Holdings is a peer of Cronos Group in medicinal chemicals and botanical products; rivals often move on the same news.
- DFTX Definium Therapeutics-11.3% 30d
Definium Therapeutics is a peer of Cronos Group in medicinal chemicals and botanical products; rivals often move on the same news.
- LLY Eli Lilly and+22.4% 30d
Eli Lilly and is a large health company like Cronos Group; big names in a sector often move together.
- JNJ Johnson & Johnson-1.7% 30d
Johnson & Johnson is a large health company like Cronos Group; big names in a sector often move together.
- ABBV AbbVie+7.8% 30d
AbbVie is a large health company like Cronos Group; big names in a sector often move together.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| CRON | -4.13% | -4.56% | base | after close | after close | after close | after close |
| XLV | -2.96% | -2.66% | base | after close | after close | after close | after close |
| RGC | +27.15% | +15.85% | base | after close | after close | after close | after close |
| DFTX | +16.03% | -0.75% | base | after close | after close | after close | after close |
| LLY | -3.15% | -0.45% | base | after close | after close | after close | after close |
| JNJ | -0.43% | -2.09% | base | after close | after close | after close | after close |
| ABBV | -1.41% | -2.06% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-05 AccNo: 0001656472-26-000074 Size: 846 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 5 Nov 2026: Cronos Group (CRON) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | three days earlier | -2.06% | final price |
| ABBV | five days earlier | -1.41% | final price |
| Cronos Group (CRON) | three days earlier | -4.56% | final price |
| Cronos Group (CRON) | five days earlier | -4.13% | final price |
| DFTX | three days earlier | -0.75% | final price |
| DFTX | five days earlier | +16.03% | final price |
| JNJ | three days earlier | -2.09% | final price |
| JNJ | five days earlier | -0.43% | final price |
| LLY | three days earlier | -0.45% | final price |
| LLY | five days earlier | -3.15% | final price |
| RGC | three days earlier | +15.85% | final price |
| RGC | five days earlier | +27.15% | final price |
| XLV | three days earlier | -2.66% | final price |
| XLV | five days earlier | -2.96% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 36 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 58 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 52 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Cronos Group (CRON)
Companies mentioned with this story
- CRON Cronos Group
In “8-K - Cronos Group Inc. (0001656472) (Filer),” Cronos Group (CRON) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> CRON
How “8-K - Cronos Group Inc. (0001656472) (Filer)” reaches Cronos Group (CRON)
The 5 Nov 2026 story “8-K - Cronos Group Inc. (0001656472) (Filer)” names Cronos Group (CRON) because of this story.
For Cronos Group (CRON), the reason on file says SEC 8-K filing -> direct issuer disclosure -> CRON
Dates in the story, and the Cronos Group (CRON) price range
CRON traded between 3.15 and 3.46 across 20 sessions. The latest close on file is 3.38.
What the saved facts support for Cronos Group (CRON)
14 out of 100
“8-K - Cronos Group Inc. (0001656472) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.